which glp 1 does hers use microdosing Hims to begin selling GLP-1 treatments Hims & Hers plans to – EllieMD vs Hers: Which To

Importantly, these metabolic improvements occurred without adverse cardiovascular effects, as the selective agonist did not increase blood pressure or heart rateside effects observed with less selective melanocortin compounds

Retatrutide, Amycretin, Survodutide, VK2735, and MariTide are among the most watched pipeline assets heading into 2026 because each represents a different answer to the same commercial question: what comes after Ozempic, Wegovy, Mounjaro, and Zepbound

Motivation low

For instance, several phase III RCTs have compared the efficacy of GLP-1RAs with that of Dipeptidyl peptidase-4 inhibitor (DPP4i) on HbA1c and weight reduction, consistently showing better performance of GLP-1RAs, as reviewed elsewhere